Search research articles
Contact Us
Filters
Showing results (51-60 of 239) with videos related to
Page
of 24
Sort By:
Differentiation; Research in Biological Diversity
|
June 8, 2011
PPARγ: a molecular link between systemic metabolic disease and benign prostate hyperplasia
Ming Jiang, Douglas W Strand, Omar E Franco, et al.
The Journal of Urology
|
September 27, 2012
Imaging the clear cell renal cell carcinoma proteome
Todd M Morgan, Erin H Seeley, Oluwole Fadare, et al.
Acta Oncologica (Stockholm, Sweden)
|
January 20, 2016
Trends in kidney cancer among the elderly in Denmark, 1980-2012
Nessn H Azawi, Simon Moeller Joergensen, Niels Viggo Jensen, et al.
Turkish Journal of Urology
|
May 16, 2020
Comparison of venous thromboembolic complications following urological surgery between patients with or without cancer
Frederik B Thomsen, Torben B Pedersen, Kasper D Berg, et al.
The Journal of Biological Chemistry
|
August 2, 2007
Tumor-derived mutations in the TRAIL receptor DR5 inhibit TRAIL signaling through the DR4 receptor by competing for ligand binding
Lianghua Bin, Jacqueline Thorburn, Lance R Thomas, et al.
Brachytherapy
|
October 22, 2008
Pretreatment prostate-specific antigen velocity is associated with freedom from biochemical recurrence of prostate cancer after low-dose-rate prostate brachytherapy alone
Peter J Rossi, James Urbanic, Peter E Clark, et al.
The Journal of Urology
|
June 15, 2007
Assessing retroperitoneal lymphadenectomy experience in United States urological residency programs
William T Lowrance, Michael S Cookson, Peter E Clark, et al.
BJU International
|
October 19, 2007
Neovesical-urethral anastomotic stricture after orthotopic urinary diversion: presentation and management
Sanjay G Patel, Michael S Cookson, Peter E Clark, et al.
Molecular Cancer Research : MCR
|
March 26, 2003
Androgen receptor activity at the prostate specific antigen locus: steroidal and non-steroidal mechanisms
Li Jia, Joshua Kim, Howard Shen, et al.
Urologic Oncology
|
September 8, 2005
Prognostic significance of clinicopathologic and deoxyribonucleic acid flow cytometric variables in non-metastatic renal cell carcinoma in the modern era
Peter E Clark, Joseph A Veys, Matthew R Eskridge, et al.
Page
of 24
Search research articles
Search
Showing results (51-60 of 239) with videos related to
Sort By:
Page
of 24
Differentiation; Research in Biological Diversity
|
June 8, 2011
PPARγ: a molecular link between systemic metabolic disease and benign prostate hyperplasia
Ming Jiang, Douglas W Strand, Omar E Franco, et al.
The Journal of Urology
|
September 27, 2012
Imaging the clear cell renal cell carcinoma proteome
Todd M Morgan, Erin H Seeley, Oluwole Fadare, et al.
Acta Oncologica (Stockholm, Sweden)
|
January 20, 2016
Trends in kidney cancer among the elderly in Denmark, 1980-2012
Nessn H Azawi, Simon Moeller Joergensen, Niels Viggo Jensen, et al.
Turkish Journal of Urology
|
May 16, 2020
Comparison of venous thromboembolic complications following urological surgery between patients with or without cancer
Frederik B Thomsen, Torben B Pedersen, Kasper D Berg, et al.
The Journal of Biological Chemistry
|
August 2, 2007
Tumor-derived mutations in the TRAIL receptor DR5 inhibit TRAIL signaling through the DR4 receptor by competing for ligand binding
Lianghua Bin, Jacqueline Thorburn, Lance R Thomas, et al.
Brachytherapy
|
October 22, 2008
Pretreatment prostate-specific antigen velocity is associated with freedom from biochemical recurrence of prostate cancer after low-dose-rate prostate brachytherapy alone
Peter J Rossi, James Urbanic, Peter E Clark, et al.
The Journal of Urology
|
June 15, 2007
Assessing retroperitoneal lymphadenectomy experience in United States urological residency programs
William T Lowrance, Michael S Cookson, Peter E Clark, et al.
BJU International
|
October 19, 2007
Neovesical-urethral anastomotic stricture after orthotopic urinary diversion: presentation and management
Sanjay G Patel, Michael S Cookson, Peter E Clark, et al.
Molecular Cancer Research : MCR
|
March 26, 2003
Androgen receptor activity at the prostate specific antigen locus: steroidal and non-steroidal mechanisms
Li Jia, Joshua Kim, Howard Shen, et al.
Urologic Oncology
|
September 8, 2005
Prognostic significance of clinicopathologic and deoxyribonucleic acid flow cytometric variables in non-metastatic renal cell carcinoma in the modern era
Peter E Clark, Joseph A Veys, Matthew R Eskridge, et al.
Page
of 24